Literature DB >> 266411

Ocular manifestations of Graves' disease: therapeutic approaches.

R M Day.   

Abstract

Entities:  

Mesh：

Year:  1977        PMID： 266411      PMCID： PMC1807340     

Source DB:  PubMed          Journal:  Bull N Y Acad Med        ISSN： 0028-7091


× No keyword cloud information.
  6 in total

1.  MANAGEMENT OF THYROTOXICOSIS IN PATIENTS WITH OPHTHALMOPATHY: ANTITHYROID REGIMEN DETERMINED PRIMARILY BY OCULAR MANIFESTATIONS.

Authors:  H ARANOW; R M DAY
Journal:  J Clin Endocrinol Metab       Date:  1965-01       Impact factor: 5.958

2.  Appearance of unilateral infiltrative exophthalmos of Graves' disease after the successful treatment of the same process in the contralateral eye by apparently total surgical hypophysectomy.

Authors:  E D FURTH; D V BECKER; B S RAY; J W KANE
Journal:  J Clin Endocrinol Metab       Date:  1962-05       Impact factor: 5.958

3.  Ocular changes in Graves' disease. A long-term follow-up study.

Authors:  I B HALES; F F RUNDLE
Journal:  Q J Med       Date:  1960-01

4.  Corticosteroids in the treatment of optic nerve involvement associated with thyroid dysfunction.

Authors:  R M Day; F D Carroll
Journal:  Arch Ophthalmol       Date:  1968-03

5.  Transantral orbital decompression for progressive exophthalmos. A follow-up of 54 cases.

Authors:  J H Ogura
Journal:  Med Clin North Am       Date:  1968-03       Impact factor: 5.456

6.  Classification of the eye changes of Grave's disease.

Authors:  S C Werner
Journal:  J Clin Endocrinol Metab       Date:  1969-07       Impact factor: 5.958
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.